X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (48) 48
Publication (5) 5
Patent (2) 2
Book Chapter (1) 1
Book Review (1) 1
Conference Proceeding (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (30) 30
humans (27) 27
female (17) 17
male (17) 17
mice (16) 16
leishmaniasis (15) 15
adult (13) 13
cutaneous leishmaniasis (13) 13
immunology (13) 13
index medicus (11) 11
adolescent (10) 10
double-blind method (10) 10
safety (10) 10
tropical medicine (10) 10
vaccine (10) 10
vaccines (10) 10
iran (9) 9
studies (9) 9
vaccination (9) 9
antigens (8) 8
leishmania major - immunology (8) 8
leishmaniasis, cutaneous - prevention & control (8) 8
medicine, research & experimental (8) 8
middle aged (8) 8
parasites (8) 8
parasitology (8) 8
visceral leishmaniasis (8) 8
double-blind (7) 7
infectious diseases (7) 7
leishmaniasis - prevention & control (7) 7
parasitic diseases (7) 7
protozoan vaccines - immunology (7) 7
child (6) 6
clinical trials (6) 6
immunotherapy (6) 6
leishmaniasis, cutaneous (6) 6
public health (6) 6
public, environmental & occupational health (6) 6
skin tests (6) 6
care and treatment (5) 5
clinical trial (5) 5
drug therapy, combination (5) 5
leishmania - immunology (5) 5
leishmaniasis - immunology (5) 5
leishmaniasis, cutaneous - drug therapy (5) 5
mice, inbred balb c (5) 5
microbiology (5) 5
protozoan vaccines - adverse effects (5) 5
review (5) 5
spleen - immunology (5) 5
world cutaneous leishmaniasis (5) 5
amazonensis vaccine (4) 4
antigens, protozoan - immunology (4) 4
arctic medicine. tropical medicine (4) 4
child, preschool (4) 4
controlled-trial (4) 4
dermal leishmaniasis (4) 4
galactosidases (4) 4
immune-response (4) 4
immunogenicity (4) 4
infections (4) 4
leishmaniasis, cutaneous - immunology (4) 4
life sciences (4) 4
plus bcg (4) 4
prevention (4) 4
protozoan vaccines - administration & dosage (4) 4
research (4) 4
t-lymphocytes - immunology (4) 4
tropical diseases (4) 4
vaccines, inactivated - adverse effects (4) 4
adjuvants, immunologic - administration & dosage (3) 3
aged (3) 3
american cutaneous leishmaniasis (3) 3
antibody formation (3) 3
antiprotozoal agents - administration & dosage (3) 3
bcg vaccine - adverse effects (3) 3
bcg vaccine - immunology (3) 3
binding sites (3) 3
brazil (3) 3
colombia (3) 3
diagnosis (3) 3
disease models, animal (3) 3
immune-responses (3) 3
immunochemotherapy (3) 3
infection (3) 3
interferon-gamma - biosynthesis (3) 3
leishmania (3) 3
leishmania amazonensis (3) 3
leishmania mexicana - immunology (3) 3
leishmaniasis vaccines - immunology (3) 3
leishmaniasis, cutaneous - pathology (3) 3
leprosy (3) 3
lesions (3) 3
medicine, general & internal (3) 3
paromomycin (3) 3
promastigotes (3) 3
public aspects of medicine (3) 3
vaccines, inactivated - administration & dosage (3) 3
vaccines, inactivated - immunology (3) 3
volunteers (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9764, pp. 477 - 486
Journal Article
Phase 1 Study of an Inactivated Vaccine against American Tegumentary Leishmaniasis in Normal Volunteers in Brazil, 12/1998
A Phase 1 double-blind placebo-controlled study was performed to evaluate a vaccine against American tegumentary leishmaniasis in 61 healthy male volunteers.... 
Leishmania - vaccine - Phase I study - side effects - Montenegro skin test
Journal
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 09/2015, Volume 9, Issue 9
  The current in vivo models for the utility and discovery of new potential anti-leishmanial drugs targeting Cutaneous Leishmaniasis (CL) differ vastly in... 
Drugs | Studies | Parasitic diseases | Clinical trials | Infections | Parasites | Trends | Pharmaceutical industry | Public health
Journal Article
Kinetoplastid Biology and Disease, ISSN 1475-9292, 08/2007, Volume 6, Issue 1, pp. 7 - 7
Post kala azar dermal leishmaniasis (PKDL) is a disease that appears after treatment of visceral leishmaniasis (VL). The highest incidence of PKDL in the world... 
Prevention | Kala-azar | International organization | Conferences, meetings and seminars | Dosage and administration | Vaccines | Diagnosis | Research
Journal Article
Journal Article
Infection and Immunity, ISSN 0019-9567, 08/2002, Volume 70, Issue 8, pp. 4215 - 4225
Journal Article
Iranian Journal of Public Health, ISSN 2251-6085, 03/2015, Volume 44, Issue 3, pp. 299 - 307
Background: Cutaneous leishmaniasis (CL) remains a serious public health concern in Kerman Province, eastern Iran. This study was aimed to conduct a... 
Cutaneous leishmaniasis | Leishmania tropica | Iran | Leishmania major | BAM DISTRICT | FOCUS | RECIDIVANS | SCHOOL-CHILDREN | EMERGENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DISEASES | ENVIRONMENTAL-CHANGE | EARTHQUAKE | TROPICA | Studies | Population growth | Surveillance | Earthquakes | Mortality | Epidemiology | Public health | Risk factors | Review
Journal Article